Steven Campbell, M.D., Ph.D.
| Appointed: |
2005 |
| Gender: |
Male |
| Languages: |
English |
Urology
Solid Tumor Oncology
Biographical Sketch
Steven Campbell, MD, PhD, is Professor of Surgery, Residency Program Director, and a member of the Section of Urologic Oncology in the Glickman Urological and Kidney Institute at Cleveland Clinic.
He obtained his medical degrees at the University of Chicago and completed his urology residency at Cleveland Clinic (1989-1995), followed by a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center (1995-1996).
Dr. Campbell’s primary interests include renal cell carcinoma, bladder cancer, prostate cancer, treatment-related osteoporosis and tumor angiogenesis. His background also includes American Foundation for Urologic Disease (AFUD) and Kimmel Research Scholarship awards, and he is a former member of the American Board of Urology Examination Committee. Dr. Campbell is currently on the educational board for AFUD and the medical advisory board for the Kidney Cancer Association.
Professional Highlights
- Residency Program Director, Cleveland Clinic, 2006-Present
- Chief of Urology, Edward Hines Jr. VA Hospital, Chicago, 2001-2005
- American Urologic Association, Boards Examination Committee, 1999-2003
- American Joint Committee on Cancer, Committee for Staging Urologic Cancers, 2006-2010
- Society of Urologic Oncology, Examination Committee
Education & Fellowships
| Medical School: | University of Chicago Pritzker School of Medicine, Chicago, IL |
|
| Internship: | Cleveland Clinic, Urology, Cleveland, OH |
| Residency: | Cleveland Clinic, Urology, Cleveland, OH |
| Fellowship: | Memorial Sloan-Kettering Cancer Center, Urology/Oncology, New York, NY |
| Other Education: | (Graduate) University of Chicago, Chicago, IL |
| Other Education: | (Undergraduate) University of Chicago, Chicago, IL |
Additional Training
- Robotic training seminars
- Laparoscopic surgery training seminars
- Laser surgery training seminars
Certifications
Specialty Interests
Bladder cancer, kidney cancer, prostate cancer, testis cancer, penile cancer, adrenal cancer, osteoporosis related to cancer, complex renal cysts.
Innovations & Patents
Dr. Campbell is active in laparoscopic surgery for the kidney and bladder and robotic surgery for the prostate, as well as new techniques for partial nephrectomy
Awards & Honors
- Best Doctors in Cleveland, 2006, 2007
- America’s Top Doctors for Cancer, 2004-2006
- America’s Top Physicians, 2004, 2005
- Best Doctors in America, 2003-2005
- Kimmel Research Scholar, 1999-2001
- American Foundation for Urologic Disease Research Scholar, 1996-1998
- Medical Scientist Training Program Scholarship Recipient, 1982-1989
- A.A. Stagg Academic/Athletic Scholarship, University of Chicago, 1978-1982
- Alpha Omega Alpha, 1989
- Phi Beta Kappa, 1981
- George and Grace Crile Traveling Fellowship Award, Cleveland Clinic Foundation, 1994
Professional Memberships
- American Urologic Association
- Society of Urologic Oncology
- Society of Pelvic Surgeons
- American College of Surgeons
- Society for Basic Urologic Research
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Campbell has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Campbell receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Pfizer Inc.
- Sanofi-Aventis US Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
